Trial site
Queen Elizabeth Hospital
- 39running trials
- 17closed trials
The trials here
What the 56 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Liver and biliary tract cancer7 trials
- Childhood cancers6 trials
- Acute myeloid leukaemia5 trials
- Gastric and oesophageal cancer5 trials
- Chronic lymphocytic leukaemia4 trials
- Head and neck cancer4 trials
- Melanoma4 trials
- Multiple myeloma4 trials
- Myelodysplastic syndromes3 trials
- Acute lymphoblastic leukaemia2 trials
- Aortic stenosis2 trials
- and 27 more
- Phase
- Phase 324 trials
- Phase 28 trials
- Phase 1/25 trials
- Phase 13 trials
- Phase 2/32 trials
- Status
- Active, not recruiting21 trials
- Completed17 trials
- Recruiting16 trials
- Not yet recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche5 trials
- University College, London4 trials
- University of Birmingham4 trials
- BeOne Medicines2 trials
- Boehringer Ingelheim2 trials
- and 37 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Active, not recruiting
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
Recruiting
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
Active, not recruiting
Recruiting
Recruiting
Recruiting
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
Active, not recruiting
Active, not recruiting
Recruiting
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
Active, not recruiting
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer
Active, not recruiting
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Active, not recruiting
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer4 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Gastric and oesophageal cancer3 recruiting
- Multiple myeloma3 recruiting
- Acute myeloid leukaemia2 recruiting
- Childhood cancers2 recruiting
- Lung cancer2 recruiting
- Melanoma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Hodgkin lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
Completed
Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
Completed
Completed
Completed
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
Completed
Completed
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026